Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
MilliporeSigma™ Supelco™ Astec™ CHIRALDEX™ B-DA Capillary GC Column, df 0.12 μm
CHIRALDEX™ B-DA requires that analytes possess a minimum of two ring structures, one of which is unsaturated (aromatic) alpha, beta to the stereogenic center. Examples include fluoxetine, methylphenidate and chloropheniramine.
Supplier: MilliporeSigma™ Supelco™ 72023AST
Description
Inclusion complexation or proper fit between the analyte and cyclodextrin cavity is the dominant enantioselectivity mechanism for the DA series. There must be an includable group alpha or beta to the stereogenic center for chiral recognition. Since CHIRALDEX™ DA columns most effectively separate multi-ring analytes, analysis temperatures are often higher than 150C. Enantioselectivity has been observed at temperatures >200°C (fluoxetine acetyl derivative).Specifications
| 0.25 mm | |
| Astec CHIRALDEX | |
| 0.12 μm | |
| Fused Silica |
| Capillary GC | |
| Gas Chromatography (GC) | |
| 30 m | |
| 2,6-di-O-pentyl-3-methoxy derivative of β-cyclodextrin |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Astec and CHIRALDEX are registered trademarks of Sigma-Aldrich Co. LLC
Spot an opportunity for improvement?
Provide Content Correction